scholarly journals Migrations of cancer cells through the lens of phylogenetic biogeography

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Antonia Chroni ◽  
Sayaka Miura ◽  
Olumide Oladeinde ◽  
Vivian Aly ◽  
Sudhir Kumar

AbstractMalignant cells leave their initial tumor of growth and disperse to other tissues to form metastases. Dispersals also occur in nature when individuals in a population migrate from their area of origin to colonize other habitats. In cancer, phylogenetic biogeography is concerned with the source and trajectory of cell movements. We examine the suitability of primary features of organismal biogeography, including genetic diversification, dispersal, extinction, vicariance, and founder effects, to describe and reconstruct clone migration events among tumors. We used computer-simulated data to compare fits of seven biogeographic models and evaluate models’ performance in clone migration reconstruction. Models considering founder effects and dispersals were often better fit for the clone phylogenetic patterns, especially for polyclonal seeding and reseeding of metastases. However, simpler biogeographic models produced more accurate estimates of cell migration histories. Analyses of empirical datasets of basal-like breast cancer had model fits consistent with the patterns seen in the analysis of computer-simulated datasets. Our analyses reveal the powers and pitfalls of biogeographic models for modeling and inferring clone migration histories using tumor genome variation data. We conclude that the principles of molecular evolution and organismal biogeography are useful in these endeavors but that the available models and methods need to be applied judiciously.

Oncotarget ◽  
2016 ◽  
Vol 7 (29) ◽  
pp. 45849-45862 ◽  
Author(s):  
Ke Su ◽  
Pengchao Hu ◽  
Xiaolan Wang ◽  
Changchun Kuang ◽  
Qingmin Xiang ◽  
...  

Oncogenesis ◽  
2020 ◽  
Vol 9 (1) ◽  
Author(s):  
Ci Xu ◽  
Meichao Zhang ◽  
Lei Bian ◽  
Yanyan Li ◽  
Yuan Yao ◽  
...  

AbstractSGK196 is a protein O-mannose kinase involved in an indispensable phosphorylation step during laminin-binding glycan synthesis on alpha-dystroglycan (α-DG). However, the function of SGK196 in cancer diseases remains elusive. In the current study, we demonstrated that SGK196 is primarily modified by N-glycosylation in breast cancer (BC) cells. Furthermore, gain and loss-of-function studies showed that N-glycosylated SGK196 suppresses cell migration, invasion, and metastasis in BC, particularly in the basal-like breast cancer (BLBC) type. In addition, we found that SGK196 N-glycosylation performs the regulatory function through the PI3K/AKT/GSK3β signaling pathway. Collectively, our results show that N-glycosylated SGK196 plays suppression roles in BLBC metastases, therefore providing new insights into SGK196 function in BC.


Sign in / Sign up

Export Citation Format

Share Document